ID: 130005404 | ATAC-STARR-seq lymphoblastoid active region 4495 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18310827..18310906) | | |
ID: 130005403 | ATAC-STARR-seq lymphoblastoid active region 4494 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18282693..18282752) | | |
ID: 130005402 | ATAC-STARR-seq lymphoblastoid active region 4493 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18282593..18282652) | | |
ID: 129390268 | MPRA-validated peak1223 silencer [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18277513..18277713) | | |
ID: 126861152 | BRD4-independent group 4 enhancer GRCh37_chr11:18343272-18344471 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18321638..18322924) | | |
ID: 106865375 | RNA, 5S ribosomal pseudogene 334 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18266396..18266512) | RN5S334 | |
ID: 106480763 | RNA, 5S ribosomal pseudogene 333 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18248389..18248506, complement) | RN5S333 | |
ID: 105376577 | uncharacterized LOC105376577 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18349117..18351879) | | |
ID: 100528017 | SAA2-SAA4 readthrough [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18231355..18248668, complement) | | |
ID: 144106 | ST13, Hsp70 interacting protein pseudogene 5 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18261885..18263501) | FAM10A5 | |
ID: 11234 | HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18278670..18322174, complement) | AIBP63, BLOC2S2 | 607521 |
ID: 6289 | serum amyloid A2 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18238236..18248668, complement) | SAA, SAA1 | 104751 |
ID: 6288 | serum amyloid A1 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18266264..18269967) | PIG4, SAA, SAA2, TP53I4 | 104750 |
ID: 2965 | general transcription factor IIH subunit 1 [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (18322567..18367045) | BTF2, P62, TFB1, TFIIH | 189972 |